Onco Therapeutics
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biotechnology
Q3
└
Biochemistry
Q4
└
Genetics
Q4
Publisher
SJR 2025
0.309
Q3
SJR Score
H-Index
3
Total Citations (3yr)
18
Publication type
Journals
ISSN
26944642, 26944650
Coverage
2021-2022
Journal Rank
#16,891
Subject Categories
Biotechnology
Q3
Biochemistry
Q4
Genetics
Q4
Molecular Medicine
Q4
Subject Areas
Detailed Metrics
| Total Docs. (3 years) | 14 |
| Total Citations (3 years) | 18 |
| Citable Docs. (3 years) | 12 |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Onco Therapeutics?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Onco Therapeutics has an SJR of 0.309 and is ranked Q3.
What is the SJR and quartile of Onco Therapeutics?
Onco Therapeutics has an SJR (SCImago Journal Rank) of 0.309 and its best quartile is Q3.
What is the H-index of Onco Therapeutics?
The H-index of Onco Therapeutics is 3, meaning 3 of its articles have each been cited at least 3 times.
Is Onco Therapeutics indexed in Scopus?
Onco Therapeutics is listed as inactive in Scopus — Scopus is no longer adding new content for this title (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.